Justice and SEC probing Merck
475211
Merck &amp; Co. said US securities regulators and the Justice Department opened inquiries concerning the painkiller Vioxx, withdrawn Sept. 30 in the biggest prescription-drug recall ever.
128777
A top Republican lawmaker called Wednesday for Merck &amp; Company to answer questions about its withdrawn drug Vioxx on Nov. 18 at the first Congressional hearing to address the drug&#39;s safety problems.
732137
U.S. health officials said on Friday they would review whether to take regulatory action over Merck & Co Inc and Schering-Plough's cholesterol medicine Vytorin following the drug's failure to work better than a generic drug in a study of plaque build-up in neck arteries.
179055
Drugmaker Merck has set up an independent committee to review the firm&#39;s actions prior to the withdrawal of its painkiller Vioxx from the market in September.
2234
Makers of the arthritis drug Vioxx and the FDA are the subject of Senate scrutiny today...and an Iowa Senator is asking the tough questions.
738069
Merck & Co. Inc.  said on Monday it had received a subpoena from the U.S. Justice Department and that the Securities and Exchange Commission has started an informal inquiry concerning its recalled pain reliever Vioxx.
171919
U.S. regulators said on Friday they  would review whether to take action over Merck & Co Inc's   and Schering-Plough Corp's  popular cholesterol  medicine Vytorin after a study showed it was no better than a  generic drug in preventing the build-up of fatty plaque.
157796
Drugs giant Merck &amp; Co. which pulled its blockbuster painkiller Vioxx from shelves in September, is about to become the target of hundreds of plaintiffs&#39; lawyers, the New York Times reported on Friday.
226044
U.S. health officials said on Friday  they would review whether to take regulatory action over Merck  & Co Inc  and Schering-Plough's  cholesterol  medicine Vytorin following the drug's failure to work better  than a generic drug in a study of plaque build-up in neck  arteries.
216989
Merck &amp; Co Inc. is evaluating why its withdrawn painkiller Vioxx raises the chance of heart attack and stroke, but it has not found a mechanism of action, a company official said on Monday.
440274
Congress has been investigating the FDA&#39;s decisions in both the Vioxx and antidepressant cases. The probes have focused on agency reviewers who warned about potential problems but claimed their research was ignored or suppressed by other officials.
428395
Merck & Co Inc. is evaluating why its withdrawn painkiller Vioxx raises the chance of heart attack and stroke, but it has not found a mechanism of action, a company official said on Monday.
266812
Merck & Co. Inc. Chief Executive  Officer Raymond Gilmartin and FDA officials have been called to  testify before Congress on Nov. 18 over safety problems with  the company's withdrawn arthritis drug Vioxx, a top U.S.  lawmaker said on Wednesday.
592608
Lawyers for customers suing Merck &amp; Co. want to question CEO Raymond Gilmartin about what he knew about the dangers of Vioxx before the company withdrew the drug from the market because of health hazards.
365737
The safety of Merck&#39;s (MRK:NYSE - news - research) Vioxx has been questioned again with the posting of an internal Food and Drug Administration study on the agency&#39;s website.
258313
Merck (nyse: MRK - news - people ) will conduct its annual analyst meeting tomorrow. The drug company is expected to provide information regarding liabilities for potential Vioxx-related lawsuits.
461726
NEW YORK -- Already wounded by the withdrawal of its Vioxx pain reliever from the market, Merck &amp; Co. must now contend with hundreds of lawsuits over the drug's side effects -- lawsuits that threaten to further damage the company's finances and reputation.